⌘K

Home/Filings/4/0001062993-25-006291

4//SEC Filing

McKelligon Brian 4

Accession 0001062993-25-006291

CIK 0001711933other

View on SEC.gov Company Profile

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 6:34 PM ET

Size

4.8 KB

Accession

0001062993-25-006291

Insider Transaction Report

Form 4

Period: 2025-03-23

Akoya Biosciences, Inc.AKYA

McKelligon Brian

DirectorPresident and CEO

Transactions

Tax Payment
Common Stock
2025-03-23$1.70/sh−7,550$12,835→ 420,126 total

Footnotes (1)

[F1]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on March 23, 2022, which vests in four (4) annual equal installments beginning on March 23, 2023 and annually thereafter until fully vested.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Akoya Biosciences, Inc.

CIK 0001711933

Entity typeother

Related Parties

1

filerCIK 0001857447

Filing Metadata

Form type: 4
Filed: Mar 24, 8:00 PM ET
Accepted: Mar 25, 6:34 PM ET
Size: 4.8 KB

View on SEC.gov